Imodium Original (Loperamide Hydrochloride)

• Imodium Original (loperamide) is used to manage acute nonspecific diarrhea by slowing intestinal transit.
• Acute nonspecific diarrhea: reduces stool frequency and improves stool consistency, providing rapid symptomatic relief in adults and children.
• Traveler’s diarrhea: offers quick control of loose stools and abdominal cramping during short‑term travel‑related episodes, helping maintain hydration.
• Diarrhea associated with chemotherapy: helps alleviate treatment‑related bowel urgency and frequency, supporting patient comfort when used under medical supervision.

• Loperamide Hydrochloride acts as a peripheral μ‑opioid receptor agonist in the myenteric plexus of the gastrointestinal tract. By binding to these receptors it inhibits acetylcholine and prostaglandin release, leading to decreased smooth‑muscle activity and prolonged intestinal transit time. The slowed motility allows greater water and electrolyte absorption, resulting in firmer stools and reduced frequency of defecation. Because loperamide poorly crosses the blood‑brain barrier, central opioid effects are minimal.

Loperamide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Constipation: hard stools or reduced bowel movements.
• Abdominal cramps: mild to moderate discomfort.
• Nausea: feeling of queasiness.
• Dizziness: light‑headed sensation.

Serious or Rare Side Effects

• Severe constipation or intestinal obstruction: risk of blockage requiring medical attention.
• Toxic megacolon: rare but life‑threatening dilation of the colon.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.

When using Imodium Original, consider the following safety measures.

• Do not exceed the recommended dose: follow label or physician guidance.
• Use caution in patients with hepatic impairment: reduced clearance may increase drug levels.
• Avoid in children under two years of age: risk of severe constipation.
• Do not use for infectious diarrhea caused by invasive bacteria (e.g., Salmonella, Shigella) without medical advice.
• Monitor for signs of constipation or abdominal distension: discontinue if severe.
• Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Loperamide can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise loperamide plasma concentrations and increase toxicity.
• Co‑administration with other antidiarrheal agents (e.g., diphenoxylate, bismuth subsalicylate): can cause additive opioid effects and severe constipation.
• Concomitant use of QT‑prolonging drugs (e.g., quinidine, certain antiarrhythmics): may enhance risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce loperamide effectiveness.
• Medications that also cause constipation (e.g., anticholinergics, calcium channel blockers): increase likelihood of intestinal blockage.
• Opioid analgesics: may augment central opioid effects, especially at high doses.